Product
IC 265
PHARMACEUTICAL
byIACTA Pharmaceuticals
United States (US)
ABOUT THE PRODUCT
An innovative ophthalmic product targeting dry eye disease, leveraging advanced delivery systems for improved patient outcomes.
Information is owner-confirmed
Last updated 0 month ago
Price range